Valuation: AbbVie Inc.

Market Cap 46TCr 15,52900Cr 41TCr 39TCr 35TCr 66TCr 44,32300Cr 66TCr 4,61400Cr 1,77600Cr 22,65900Cr 1,73600Cr 1,69800Cr 72,64500Cr P/E 2026 *
33.1x
P/E 2027 * 24.7x
Enterprise Value 52TCr 17,59800Cr 46TCr 44TCr 39TCr 74TCr 50,22800Cr 75TCr 5,22900Cr 2,01200Cr 25,67800Cr 1,96700Cr 1,92400Cr 82,32400Cr EV / Sales 2026 *
7.75x
EV / Sales 2027 * 7.01x
Free-Float
95.71%
Yield 2026 *
2.65%
Yield 2027 * 2.76%
1 day-1.12%
1 week-0.56%
1 month+4.14%
3 months+3.53%
6 months+24.82%
Current year+20.55%
1 week 8.75
Extreme 8.75
9
1 month 8.15
Extreme 8.15
9
Current year 6.25
Extreme 6.25
9
1 year 6.25
Extreme 6.25
9
3 years 6.25
Extreme 6.25
9
5 years 6.25
Extreme 6.25
9
10 years 6.25
Extreme 6.25
9
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO 59 23/06/2022
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 65 01/01/2013
Director/Board Member 74 01/01/2013
Director/Board Member 69 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%-0.56% - - 46TCr
-0.90%-2.31%+39.88%+114.50% 1,03100Cr
-0.39%-2.51%+41.83%+70.08% 64TCr
+0.08%-1.42%+6.95%+76.30% 46TCr
-0.59%-2.05%+60.81%+41.34% 36TCr
-0.01%-3.47%+24.26%+41.42% 33TCr
-1.30%+0.05%+14.42%+27.47% 27TCr
-1.29%-1.69%-1.98%+11.32% 25TCr
-0.58%+3.43%+40.70%+57.70% 23TCr
-0.29%-0.51%+33.99%+100.99% 18TCr
Average -0.63%-0.36%+28.99%+60.12% 41.82TCr
Weighted average by Cap. -0.64%-0.35%+31.87%+71.45%

Financials

2026 *2027 *
Net sales 6.76TCr 2,27100Cr 5.95TCr 5.64TCr 5.09TCr 9.6TCr 6,48200Cr 9.72TCr 67TCr 26TCr 3,31400Cr 25TCr 25TCr 10,62300Cr 7.35TCr 2,46900Cr 6.47TCr 6.13TCr 5.54TCr 10TCr 7,04700Cr 11TCr 73TCr 28TCr 3,60300Cr 28TCr 27TCr 11,55000Cr
Net income 1.41TCr 47TCr 1.24TCr 1.17TCr 1.06TCr 2TCr 1,34900Cr 2.02TCr 14TCr 5.4TCr 69TCr 5.28TCr 5.17TCr 2,21100Cr 1.9TCr 64TCr 1.68TCr 1.59TCr 1.43TCr 2.7TCr 1,82600Cr 2.74TCr 19TCr 7.32TCr 93TCr 7.15TCr 7TCr 2,99300Cr
Net Debt 6.16TCr 2,06900Cr 5.42TCr 5.14TCr 4.64TCr 8.74TCr 5,90600Cr 8.86TCr 61TCr 24TCr 3,01900Cr 23TCr 23TCr 9,67900Cr 5.31TCr 1,78400Cr 4.68TCr 4.43TCr 4TCr 7.54TCr 5,09100Cr 7.63TCr 53TCr 20TCr 2,60200Cr 20TCr 20TCr 8,34300Cr
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
30/26/30 THB 8.800 -1.12% 41,191
29/26/29 THB 8.900 -0.56% 3,685
28/26/28 THB 8.950 +1.13% 2,308
25/26/25 THB 8.850 +0.57% 14,085
24/26/24 THB 8.800 -0.56% 29,190
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
261.59USD
Average target price
278.86USD
Spread / Average Target
+6.60%

Quarterly revenue - Rate of surprise